Opinion Conversations on the science of autism research.

Valproate fate

by  /  5 June 2012

Human pregnancy lasts almost a year, and over that time, women are exposed to many things, some of which have serious consequences for the developing fetus.

Rodents exposed to valproate are probably the most studied environmental models of autism — and with good reason. These animals have repetitive behaviors, social deficits and abnormal patterns of super-fast brain waves, all reminiscent of symptoms in people with the disorder.

A new rat study adds another level of complexity, showing that the precise timing of early valproate exposure can have a big influence on behavior later on.

In several older studies, researchers gave valproate to pregnant rats around embryonic day 12, the equivalent of the first trimester in a human pregnancy. This leads to abnormal social behaviors, as well as impaired motor development and an increased sensitivity to tactile and auditory stimulation in the offspring. This last feature is intriguing because many people with autism have severe sensory sensitivities, frequently cowering from loud noises or bright lights.

In the new study, published 24 May in Developmental Neuroscience, researchers gave valproate to rats during postnatal days 6 to 12, the approximate equivalent of the third trimester in pregnant women. Surprisingly, this exposure leads to the opposite sensory behaviors: The offspring are less sensitive to sounds and touch.

Although hyposensitivity is less commonly studied than hypersensitivity, both seem to be fairly common among people with autism. Some children don’t respond to their name being called, for example, or don’t react to pain.

Valproate exposure is rare, accounting for a small proportion of all cases of autism. Still, these new findings hint at the dynamic changes that happen during early brain development. These changes don’t stop in infancy, of course. Some researchers have proposed giving valproate later in a child’s development, after age 2, as a treatment for autism. As an anti-epileptic, the drug can suppress excess brain waves that may contribute to some symptoms of autism.

When studying genetic and environmental factors that contribute to autism, asking what may not be as important as asking when.

  • Jon Brock

    Interesting. Although presumably kids who are exposed to valproate are usually exposed throughout the whole pregnancy. Given that the same person with autism can be both hypo and hypersensitive depending on the situation, the story is going to be pretty complicated.

  • usethebrainsgodgiveyou

    Attention is fragile…to this day, if I am entranced with something on the web, reading or writing, I will not hear my husband talk to me. I have only one channel of attention.

    Being highly visual, autistic children may not react to hearing as readily as seeing, possible reasons why they are entranced with motion far more than sound. Thus, they aren’t ignoring their name as much as the input channel. With language deficits,the problem can be their name does not yet have meaning to them. Maybe they think their name is “you”, as in, “You want to go to the park?” “You go to park” means yes.My son says maybe he was just choosing to ignore me…but that he actually doesn’t remember that far back.

    This is very responsible, to equate possible etiology as iantrogenic. I had no idea that 6-9% exposed to valproate in-utero developed autism. That is amazing.

    The “clumsiness” sometimes equated with aspergers could possibly be an inability to establish adequate motor responses, because of lack of sensitivity to vestibular/kinesthetic in-put. Would a hypo-sensitive child test out as clumsy, while a hypersensitive child test as being hyper-athletic? I’ve heard of both types, especially hyper-acute children having phenomenal balance.

    There are no end of questions, and too few answers.


Log in to your Spectrum Wiki account

Email Address:



Request your Spectrum Wiki account

Spectrum Wiki is a community of researchers affiliated with an academic or research institutions. To be considered for participation, please fill out this form and a member of our team will respond to your request.


Email Address:

Title and Lab:

Area of Expertise: